Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: Valid predictors of symptomatic response and remission?

References

• American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association.
   Google Scholar
• Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. 2005. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162:441–449.
   PubMed Web of Science ®Google Scholar
• Bobes J, Garcia-Portilla P, Saiz PA, Bascaran T, Bousono M. 2005. Quality of life measures in schizophrenia. Eur Psychiatry 20 Suppl 3:S313–317.
   Google Scholar
• Bobon DP, Lapierre YD, Lottin T. 1981. Validity and sensitivity of the french version of the Zerssen BfS/BfS’ self-rating mood scale during treatment with trazodone and amitriptyline. Prog Neuropsychopharmacol 5:519–522.
   PubMedGoogle Scholar
• Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, . 1996. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 94:118–124.
   PubMed Web of Science ®Google Scholar
• Caspi A, Reichenberg A, Weiser M, Rabinowitz J, Shmushkevich M, Lubin G, . 2007. Premorbid behavioral and intellectual functioning in schizophrenia patients with poor response to treatment with antipsychotic drugs. Schizophr Res 94:45–49.
   PubMed Web of Science ®Google Scholar
• Cording C. 1998. [Conceptual aspects in development and implementation of basic psychiatric documentation]. Psychiatr Prax 25:175–178.
   PubMedGoogle Scholar
• de Haan L, Nimwegen L, Amelsvoort T, Dingemans P, Linszen D. 2008. Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia. Pharmacopsychiatry 41:125–128.
   PubMed Web of Science ®Google Scholar
• Donohoe G, Owens N, O'Donnell C, Burke T, Moore L, Tobin A, O'Callaghan E. 2001. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. Eur Psychiatry 16:293–298.
   PubMed Web of Science ®Google Scholar
• Emsley R, Oosthuizen PP, Kidd M, Koen L, Niehaus DJ, Turner HJ. 2006. Remission in first-episode psychosis: predictor variables and symptom improvement patterns. J Clin Psychiatry 67:1707–1712.
   PubMed Web of Science ®Google Scholar
• Emsley R, Rabinowitz J, Medori R. 2007. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophr Res 89:129–139.
   PubMed Web of Science ®Google Scholar
• Emsley R, Chiliza B, Schoeman R. 2008. Predictors of long-term outcome in schizophrenia. Curr Opin Psychiatry 21:173–177.
   PubMed Web of Science ®Google Scholar
• Fahrmeir L, Kneib T, Lang S. 2007. Linear regression models. Regression; Modelle, Methoden und Anwendungen. Berlin: Springer. 59–188.
   Google Scholar
• Gaebel W. 1996. Prediction of response to acute neuroleptic treatment in schizophrenia. Int Clin Psychopharmacol 11(Suppl 2):47–54.
   PubMedGoogle Scholar
• Hofer CK, Zollinger A, Buchi S, Klaghofer R, Serafino D, Buhlmann S, . 2003. Patient well-being after general anaesthesia: a prospective, randomized, controlled multi-centre trial comparing intravenous and inhalation anaesthesia. Br J Anaesth 91:631–637.
   PubMed Web of Science ®Google Scholar
• Hothorn T, Hornik K, Zeileis A. 2006. Unbiased recursive partitioning: a conditional inference framework. J Comput Graphical Stat 3:651–674.
   Google Scholar
• Jager M, Riedel M, Messer T, Laux G, Pfeiffer H, Naber D, . 2007. Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders. Eur Arch Psychiatry Clin Neurosci 257:47–53.
   PubMed Web of Science ®Google Scholar
• Katschnig H. 2000. Schizophrenia and quality of life. Acta Psychiatr Scand Suppl 33–37.
   PubMedGoogle Scholar
• Kay SR, Opler LA, Lindenmayer JP. 1988. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 23:99–110.
   PubMed Web of Science ®Google Scholar
• Kemp R, David A. 1996. Psychological predictors of insight and compliance in psychotic patients. Br J Psychiatry 169:444–450.
   PubMed Web of Science ®Google Scholar
• Kemp R, Hayward P, Applewhaite G, Everitt B, David A. 1996. Compliance therapy in psychotic patients: randomised controlled trial. Br Med J 312:345–349.
   PubMed Web of Science ®Google Scholar
• Kemp R, Kirov G, Everitt B, Hayward P, David A. 1998. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry 172:413–419.
   PubMed Web of Science ®Google Scholar
• Lambert M, Naber D. 2004. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 18(Suppl 2):5–17.
   PubMedGoogle Scholar
• Lambert M, Schimmelmann BG, Karow A, Naber D. 2003. Subjective well-being and initial dysphoric reaction under antipsychotic drugs – concepts, measurement and clinical relevance. Pharmacopsychiatry 36(Suppl 3):S181–190.
   PubMedGoogle Scholar
• Lambert M, Schimmelmann BG, Naber D, Schacht A, Karow A, Wagner T, Czekalla J. 2006. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 67:1690–1697.
   PubMed Web of Science ®Google Scholar
• Lambert M, Naber D, Eich FX, Schacht M, Linden M, Schimmelmann BG. 2007. Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride. Acta Psychiatr Scand 115:106–113.
   PubMed Web of Science ®Google Scholar
• Lambert M, Schimmelmann BG, Schacht A, Karow A, Wagner T, Wehmeier PM, . 2009. Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years. Schizophr Res 107:165–172.
   PubMed Web of Science ®Google Scholar
• Lasser RA, Bossie CA, Gharabawi GM, Kane JM. 2005. Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection. Schizophr Res 77:215–227.
   PubMed Web of Science ®Google Scholar
• Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, . 2004. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. J Clin Psychiatry 65:551–556.
   PubMed Web of Science ®Google Scholar
• Marder SR, Meibach RC. 1994. Risperidone in the treatment of schizophrenia. Am J Psychiatry 151:825–835.
   PubMed Web of Science ®Google Scholar
• Moller HJ, von ZD. 1982. Depressive states occurring during the neuroleptic treatment of schizophrenia. Schizophr Bull 8:109–117.
   PubMed Web of Science ®Google Scholar
• Naber D. 1995. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 10 (Suppl 3):133–138.
   PubMedGoogle Scholar
• Naber D, Moritz S, Lambert M, Pajonk FG, Holzbach R, Mass R, Andresen B. 2001. Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs. Schizophr Res 50:79–88.
   PubMed Web of Science ®Google Scholar
• Narvaez JM, Twamley EW, McKibbin CL, Heaton RK, Patterson TL. 2008. Subjective and objective quality of life in schizophrenia. Schizophr Res 98:201–208.
   PubMed Web of Science ®Google Scholar
• Peuskens J. 1995. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Br J Psychiatry 166:712–726.
   PubMed Web of Science ®Google Scholar
• Pukrop R, Schlaak V, Moller-Leimkuhler AM, Albus M, Czernik A, Klosterkotter J, Moller HJ. 2003. Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression. Psychiatry Res 119:63–79.
   PubMed Web of Science ®Google Scholar
• R Development Core Team. A language and environment for statistical computing. URL http://www.R-project.org. 2008. Vienna, Austria, Foundation for Statistical Computing.
   Google Scholar
• Ref Type: Computer Program.
   Google Scholar
• Sethuraman G, Taylor CC, Enerson M, Dunayevich E. 2005. A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia. Schizophr Res 79:337–340.
   PubMed Web of Science ®Google Scholar
• Simonsen E, Friis S, Haahr U, Johannessen JO, Larsen TK, Melle I, . 2007. Clinical epidemiologic first-episode psychosis: 1-year outcome and predictors. Acta Psychiatr Scand 116:54–61.
   PubMed Web of Science ®Google Scholar
• Skantze K, Malm U, Dencker SJ, May PR, Corrigan P. 1992. Comparison of quality of life with standard of living in schizophrenic out-patients. Br J Psychiatry 161:797–801.
   PubMed Web of Science ®Google Scholar
• Tunis SL, Croghan TW, Heilman DK, Johnstone BM, Obenchain RL. 1999. Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol. Med Care 37:678–691.
   PubMed Web of Science ®Google Scholar
• Valenstein M, Ganoczy D, McCarthy JF, Myra KH, Lee TA, Blow FC. 2006. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. J Clin Psychiatry 67:1542–1550.
   PubMed Web of Science ®Google Scholar
• Van OJ, Burns T, Cavallaro R, Leucht S, Peuskens J, Helldin L, . 2006. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand 113:91–95.
   PubMedGoogle Scholar
• von Zerssen D, Koeller DM. 1976. Die Befindlichkeitsskala. Parallelformen Bf-S und Bf-S’. Weinheim: Beltz Test Gesellschaft mbH.
   Google Scholar
• Ware JE Jr. 2000. SF-36 health survey update. Spine 25:3130–3139.
   PubMed Web of Science ®Google Scholar
• Ware JE Jr, Sherbourne CD. 1992. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483.
   PubMed Web of Science ®Google Scholar
• Weinstein MC, Fineberg HV. 1980. Clinical decisions analysis. Philadelphia, PA: WB Saunders.
   Google Scholar
• Wolwer W, Buchkremer G, Hafner H, Klosterkotter J, Maier W, Moller HJ, Gaebel W. 2003. German research network on schizophrenia-bridging the gap between research and care. Eur Arch Psychiatry Clin Neurosci 253:321–329.
   PubMed Web of Science ®Google Scholar